LFMD LifeMD, Inc.
LFMD LifeMD, Inc.
Healthcare · Health Information Services
Market read
POC $3.64 · VWAP $3.89 · -45.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
LFMD Price Structure
Loading timeframes…
Peers
Every watchlist LFMD belongs to, members best 30-day change first — LFMD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
Reported the quarter ending 2026-06-30: revenue $47M, diluted EPS -$0.16, net income -$7M (SEC filing). Across the print the stock moved -12.8% (close before → first close after).
full note →Against street estimates
How LFMD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about LFMD from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 38 days ago · Sep 15
- LFMD: LifeMD Inc - Stock Price, Quote and News - CNBC
- LifeMD Earnings & Forecasts - Benzinga
- LifeMD (LFMD) Earnings Date and Reports 2026 $LFMD
- Earnings call transcript: LifeMD Q1 2026 beats EPS and revenue forecasts By Investing.com
- LifeMD (LFMD) Investor Relations, Earnings Summary & Outlook
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
LFMD research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.